GL1X · GenesisL1 explorer

MolNFT v1 · #183229 · protein

14-3-3 sigma with AS160 binding site PT642

7NIX · 14-3-3 protein sigma: “14-3-3 sigma with AS160 binding site PT642”. X-ray diffraction, 1 ligand (MG), 1 pocket (best druggability 0.54). MolNFT v1 #183229 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7NIX
Type
protein
Length
242 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
14-3-3 protein sigma; TBC1 domain family member 4
UniProt
P31947, O60343
Ligands
MG
Pockets
1 · best druggability 0.54

Structure

x-ray diffraction · 2 distinct chains · 81% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A14-3-3 protein sigmaprotein23184% helix, 0% strandP31947
BTBC1 domain family member 4protein110% helix, 0% strandO60343

Ligands and binding sites

  • MG · Magnesium ion · metal · 2 copies · chains A
  • NHE · 2-[N-cyclohexylamino]ethane sulfonic acid · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11100.540.8325empty

Interfaces

1 interface between chains.

  • A–B · 839 Ų buried · 20 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 7NIX · 14-3-3 sigma with AS160 binding site pT642 · the same entry in another collection · chain A against A, TM-score 1.00
  • P31947 · AlphaFold monomer V2.0 prediction for 14-3-3 protein sigma (P31947) · a predicted model of the same protein · chain A against A, TM-score 0.96
  • O60343 · AlphaFold monomer V2.0 prediction for TBC1 domain family member 4 (O60343) · a predicted model of the same protein · chain B against A, TM-score 0.33

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.